| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.10. | Fresenius Takes Full Ownership of mAbxience | ||
| 30.09. | T-CURX Appoints Florian Schmid Chief Financial Officer | ||
| 30.09. | Ensera Forms Alliance Network Uniting Device Platform & Fill-Finish Specialists | ||
| 30.09. | Piramal, NP2 Partner to Tackle Cyclophosphamide Shortages | ||
| 30.09. | Minaris Adds Dedicated Viral Vector Business Unit | ||
| 30.09. | ai3Bio Launches as Biotech Targeting Autoimmune Disease | ||
| 30.09. | ALK, Catalent Expand Long-Term Contract Manufacturing Collaboration | ||
| 30.09. | SK pharmteco to Invest Over $200M in U.S. Over Next 5 Years | ||
| 30.09. | OnDosis, Adare Partner on ADHD Drug | ||
| 30.09. | BioMed X, AbbVie Launch Anhedonia Research Team | ||
| 30.09. | Ontario Invests $1.75M in Piramal Pharma's Aurora Site | ||
| 29.09. | Neurocrine Biosciences Welcomes Back Eiry Roberts as Chief Medical Officer | ||
| 29.09. | ESTEVE CDMO Invests Additional $17.5M in Illinois Site | ||
| 29.09. | Forge, TECPR2 Research Foundation Strike AAV Gene Therapy Development, Manufacturing Partnership | ||
| 29.09. | Evotec Searches for New Chief Scientific Officer | ||
| 29.09. | Genentech Breaks Ground on $750M Expansion in Hillsboro, Oregon | ||
| 29.09. | AstraZeneca Makes $2B Equity Investment in Summit Therapeutics | ||
| 29.09. | Quotient, Acesion Partner on AI Drug Development | ||
| 29.09. | Almac Appoints Cheryl Kole as President and Managing Director | ||
| 29.09. | Axplora Expands Exatecan Options for ADC Developers | ||
| 29.09. | Novo Nordisk Signs $2.6B Hengrui Oral GLP-1 Deal | ||
| 29.09. | Serán Bioscience Secures Growth Investment | ||
| 28.09. | Circle Pharma Makes Two Executive Team Announcements | ||
| 28.09. | Lilly's Olumiant OKed by FDA for Pediatric Patients Over 12 with Severe Alopecia Areata | ||
| 28.09. | Thermo Fisher Launches Nicolet RaptIR X FTIR Microscope |